Like all of the other inhibitors of HDAC, belinostat PXD101 is also an efficient kinase inhibitor of HDACs. It is relatively newer inhibitor and there is still a lot of space in experiments concentrating on the elucidation of it's mechanism of action as a result of HTS together with computational approaches. Also, there is a lot of room in the development of its analogs just by virtual screening technology. Being successful in aiming and preventing ovarian cancer, bladder cancer whilst others, belinostat is no doubt a useful addition to compound libraries for HTS.
Belinostat: A Potent HDI in HTS
Posted by marcmolecular112 (#1864) 121 days ago (http://suzanewill322.newsvine.com)Who Voted for this Story
Vermontaco Social Bookmark provides valuable contents to its Readers
